InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the full record of transactions filed by McMillan Wayde D., Chief Financial Officer. Director active across 2 companies, notably INSULET CORP. In total, 12 disclosures have been recorded. Total volume traded: €453k. The latest transaction was filed on 13 May 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
09,503 shares0
Common Stock
SEC:0001768648-26-000005·
09,503 shares0
Common Stock
SEC:0001768648-26-000005:0·
€362,1611,455 shares@ €248.90810.0035% mcap49.6% of flow
Common Stock
SEC:0001127602-22-011546:0·
02,361 shares0
Common Stock
SEC:0001127602-22-007729:0·
€122,385522 shares@ €234.45380.0012% mcap16.7% of flow
Common Stock
SEC:0001127602-22-007009:0·
07,057 shares0
Common Stock
SEC:0001127602-22-006035:0·
€32,389153 shares@ €211.69610.0003% mcap4.4% of flow
Common Stock
SEC:0001127602-22-005765:0·
€32,389153 shares@ €211.69610.0003% mcap26.3% of flow
Common Stock
SEC:0001127602-22-005765·
€45,376205 shares@ €221.34530.0004% mcap36.8% of flow
Common Stock
SEC:0001127602-22-004559·
€45,376205 shares@ €221.34530.0004% mcap6.2% of flow
Common Stock
SEC:0001127602-22-004559:0·
€45,395193 shares@ €235.20470.0004% mcap36.9% of flow
Common Stock
SEC:0001127602-22-000457·
€45,395193 shares@ €235.20470.0004% mcap6.2% of flow
Common Stock
SEC:0001127602-22-000457:0·
12 of 12 declarations
About McMillan Wayde D.
Wayde D. McMillan is the CFO and Executive Vice President at Insulet Corp and Solventum Corp. In this role, he is responsible for the financial management of the companies, including financial planning, risk management, and financial reporting. His experience in the medical and technology sectors allows him to provide valuable expertise to support the companies' growth. He plays a key role in developing the financial strategy for the firms.
